Hyperthyroidism: Methimazole Plus L-carnitine and Selenium
NCT ID: NCT04946123
Last Updated: 2025-06-08
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
60 participants
INTERVENTIONAL
2021-07-05
2025-06-04
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Treatment of Graves' Hyperthyroidism With Selenium Plus Methimazole
NCT02727738
Block-replacement Therapy During Radioiodine Therapy
NCT00150124
Effects of L-thyroxine Replacement on Serum Lipid and Atherosclerosis in Hypothyroidism
NCT01848171
Desiccated Thyroid Extract and Levothyroxine for Hypothyroidism Treatment
NCT01739972
Effects of L-carnitine on Hypothyroidism
NCT01769157
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
methimazole (control)
Patients with hyperthyroidism under methimazole treatment
No interventions assigned to this group
methimazole+L-carnitine+selenium (intervention)
Patients with hyperthyroidism under methimazole treatment + supplementation with L-carnitine and Selenium
L-carnitine+Selenium
Supplementation with L-carnitine and Selenium
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
L-carnitine+Selenium
Supplementation with L-carnitine and Selenium
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* Pregnancy;
* Medically uncontrolled psychiatric conditions;
* Interfering therapies (lithium, interferone, TKI, amiodarone)
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Lo.Li.Pharma s.r.l
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Azienda Ospedaliero-Universitaria Città della scienza e degli studi di Torino
Torino, , Italy
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
L-carnitine Hyperthyroidism
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.